封面
市場調查報告書
商品編碼
1603302

醫用塑膠市場規模、佔有率、成長分析,按類型、應用、工藝、地區分類 - 產業預測,2024-2031 年

Medical Plastics Market Size, Share, Growth Analysis, By Type(Standard Plastics, Engineering Plastics, High Performance Plastic ), By Application, By Process, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球醫用塑膠市場規模估值為465億美元,從2023年的501.3億美元成長到2031年的985.5億美元,預計在預測期內(2024-2031年)複合年成長率為7.8%。美元。

醫用塑膠市場的特點是可以模製成各種形狀的聚合物,例如聚碳酸酯、聚丙烯和聚乙烯,由於醫療保健投資的增加和消費者健康意識的提高,預計該市場將顯著成長。醫用聚合物獨特的耐熱和耐化學性能使其成為各種醫療設備和儀器(包括手術管)的理想材料。隨著可支配收入的增加和消費者生活方式的發展,預計未來幾年對醫用塑膠的需求將會增強。 2022 年第一季季的醫療設備新增銷售量最初因社交距離和封鎖而下降,但COVID-19 大流行導致實驗室外套、口罩和手套等一次性醫療產品的銷售增加,刺激了對醫療器材的需求。個人防護設備(PPE)的一次性使用作為安全通訊協定已經激增,凸顯了市場的適應性。儘管疫情帶來挑戰,但醫用塑膠產業正在復甦,預計將穩步恢復勢頭,反映出該行業在市場動態變化中的韌性。總體而言,全球醫用塑膠市場繼續在新冠疫情後的格局中前行,同時利用消費者不斷變化的健康優先事項,前景仍然樂觀。

目錄

介紹

  • 研究目的
  • 調查範圍
  • 定義

調查方法

  • 資訊採購
  • 二手資料和主要資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 抑制因素和挑戰
  • 波特分析及影響
    • 競爭公司之間的敵對關係
    • 替代品的威脅
    • 買方議價能力
    • 新進入者的威脅
    • 供應商的議價能力

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 技術進步
  • 監管環境
  • 價值鏈分析
  • 案例研究分析
  • 客戶和購買標準分析
  • PESTEL分析
  • 總體經濟指標
  • 市場吸引力指數
  • 原料分析
  • 供應鏈分析
  • 價格分析

醫用塑膠市場規模:按類型和複合年成長率(2024-2031)

  • 標準塑膠
  • 聚氯乙烯(PVC)
  • 聚烯(PE)
  • 聚丙烯(PP)
  • 聚苯乙烯(PS)
  • 聚甲基丙烯酸甲酯 (PMMA)
  • 工程塑膠
  • 聚醯胺 (PA)
  • 丙烯腈丁二烯苯乙烯 (ABS)
  • 聚碳酸酯(PC)
  • 聚縮醛
  • 其他
  • 高性能塑膠(HPP)
  • 聚醚醚酮 (PEEK)
  • 聚四氟乙烯 (PTFE)
  • 聚苯碸 (PPSU)
  • 其他HPPS
  • 矽膠
  • 其他
  • 熱可塑性橡膠(TPE)
  • 熱塑性聚氨酯(TPU)
  • 生物分解性聚合物
  • 聚合物共混物和合成橡膠

醫用塑膠市場規模:按應用和複合年成長率(2024-2031)

  • 醫療一次性產品
  • 常見的一次性產品
  • 醫療袋
  • 導管
  • 注射器
  • 義肢
  • 義足
  • 植入
  • 醫療設備和工具
  • 手術器械
  • 診斷器材與設備
  • 牙科器械
  • 藥物輸送
  • 其他

醫用塑膠市場規模:按工藝和複合年成長率(2024-2031)

  • 擠壓
  • 射出成型
  • 吹塑成型
  • 其他

醫用塑膠市場規模:按地區和複合年成長率(2024-2031)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲

競爭資訊

  • 前5名企業對比
  • 主要企業市場定位(2023年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2023)
  • 主要企業簡介
    • 公司簡介
    • 產品系列分析
    • 按細分市場分類的佔有率分析
    • 收益與前一年同期比較(2021-2023)

主要企業簡介

  • Rochling SE & Co. KG
  • Nolato AB
  • Saint-Gobain
  • SABIC
  • Eastman Chemical Company
  • Dow, Inc.
  • Solvay SA
  • HMC Polymers Company Limited
  • ARAN BIOMEDICAL TEORANTA
  • Avantor, Inc.
  • Trinseo
  • Evonik Industries AG
  • BASF
  • Covestro
  • Arkema
  • Mitsubishi Chemical Corporation

結論和建議

簡介目錄
Product Code: SQMIG15E2132

Global Medical Plastics Market size was valued at USD 46.5 billion in 2022 and is poised to grow from USD 50.13 billion in 2023 to USD 98.55 billion by 2031, growing at a CAGR of 7.8% in the forecast period (2024-2031).

The medical plastics market, characterized by polymers such as polycarbonate, polypropylene, and polyethylene that can be molded into diverse shapes, is set for significant growth driven by heightened investments in healthcare and increasing consumer health awareness. The inherent properties of medical-grade polymers, which are resistant to heat and chemicals, position them as ideal materials for a range of medical devices and equipment, including surgical tubing. As disposable incomes rise and consumer lifestyles evolve, demand for medical plastics is expected to intensify in the coming years. Notably, the COVID-19 pandemic spurred demand for disposable medical products, such as test gowns, masks, and gloves, despite an initial dip in new medical device sales during Q1 and Q2 of 2022 attributed to social distancing measures and lockdowns. The preference for single-use personal protective equipment (PPE) surged as a safety protocol, highlighting the adaptability of the market. Although the pandemic presented challenges, the medical plastics sector is rebounding and is expected to steadily regain momentum, reflecting the resilience of the industry amidst changing market dynamics. Overall, the outlook for the global medical plastics market remains positive as it continues to navigate the post-COVID landscape while leveraging evolving consumer health priorities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Plastics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Medical Plastics Market Segmental Analysis

Global Medical Plastics Market is segmented by Type, by Product, by Application, by Process and by Region. Based on Type, the market is segmented into Standard Plastics, Engineering Plastics, High Performance Plastic (HPP), Silicone, and Others. Based on Application, the market is segmented into Medical disposables, Prosthetics, Medical Instruments & Tools, Drug Delivery, and Others. Based on Process, the market is segmented Extrusion, Injection Molding, Blow Molding, Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Medical Plastics Market

The global Medical Plastics market is being significantly propelled by the increasing demand for recyclable medical plastics, driven largely by the expansion of the medical sector worldwide. The ongoing COVID-19 pandemic has led to a surge in the use of single-use medical plastics and consumables within healthcare facilities, necessitating items such as thermal scanners, ventilators, gloves, respirators, and masks in hospitals, clinics, and diagnostic centers. Additionally, innovations in medical polymers improving biocompatibility are enhancing cost-effectiveness and enabling advancements in targeted drug delivery systems. Furthermore, the rapid development of healthcare infrastructure in emerging markets, coupled with a growing elderly population, is expected to further stimulate market growth.

Restraints in the Global Medical Plastics Market

The Global Medical Plastics market faces significant restraints due to growing concerns about environmental sustainability. The surge in population results in heightened demand for plastic products, which in turn leads to increased plastic production and waste, contributing to environmental pollution. Many medical plastics are non-recyclable and are often discarded individually to manage infection control, complicating waste management efforts. This situation has intensified issues like soil and water degradation. Additionally, the COVID-19 pandemic has escalated plastic use, further straining the environment. Consequently, stringent environmental regulations may adversely impact the demand for medical plastics and stifle industry growth.

Market Trends of the Global Medical Plastics Market

The Global Medical Plastics market is witnessing a notable trend of price volatility driven by fluctuating oil prices, which significantly influences the costs of key polymers such as Polyvinyl Chloride (PVC), Polyethylene (PE), Polypropylene (PP), and Polystyrene (PS). This instability is further compounded by shifts in industry capacity expansions and reductions, particularly in response to demand fluctuations. Additionally, overproduction in the Chinese market is anticipated to exert pressure on raw material prices, creating further uncertainty in the market. Amidst this, companies are adapting strategies to stabilize supply chains, highlighting an ongoing struggle between maintaining market stability and navigating price uncertainties.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Value Chain Analysis
  • Case Study Analysis
  • Customer & Buying Criteria Analysis
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Market Attractiveness Index
  • Raw Material Analysis
  • Supply Chain Analysis
  • Pricing Analysis

Global Medical Plastics Market Size by Type & CAGR (2024-2031)

  • Standard Plastics
  • Polyvinyl Chloride (PVC)
  • Polyolefin (PE)
  • Polypropylene (PP)
  • Polystyrene (PS)
  • Poly (Methyl Methacrylate) (PMMA)
  • Engineering Plastics
  • Polyamide (PA)
  • Acrylonitrile Butadiene Styrene (ABS)
  • Polycarbonate (PC)
  • Polyacetal
  • Others
  • High Performance Plastic (HPP)
  • Polyetheretherketone (PEEK)
  • Polytetrafluoroethylene (PTFE)
  • Polyphenylsulfone (PPSU)
  • Other HPPS
  • Silicone
  • Others
  • Thermoplastic Elastomer (TPE)
  • Thermoplastic Polyurethane (TPU)
  • Biodegradable Polymers
  • Polymer Blends and Synthetic Rubber

Global Medical Plastics Market Size by Application & CAGR (2024-2031)

  • Medical Disposables
  • General Disposables
  • Medical Bags
  • Catheters
  • Syringes
  • Prosthetics
  • Limb Prosthesis
  • Implants
  • Medical Instruments & Tools
  • Surgical Instruments
  • Diagnostic Instruments & Devices
  • Dental Tools
  • Drug Delivery
  • Others

Global Medical Plastics Market Size by Process & CAGR (2024-2031)

  • Extrusion
  • Injection Molding
  • Blow Molding
  • Other

Global Medical Plastics Market Size by Region & CAGR (2024-2031)

  • North America, (by Type, by Application, by Process)
    • US
    • Canada
  • Europe, (by Type, by Application, by Process)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (by Type, by Application, by Process)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (by Type, by Application, by Process)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (by Type, by Application, by Process)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Rochling SE & Co. KG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nolato AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Saint-Gobain
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SABIC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eastman Chemical Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dow, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Solvay S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HMC Polymers Company Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ARAN BIOMEDICAL TEORANTA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avantor, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trinseo
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Evonik Industries AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BASF
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Covestro
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arkema
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mitsubishi Chemical Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation